Eligible patients may pay no more than $20* for a prescription of either Quillivant XR or QuilliChew ER

Submitted by admin on Thu, 03/03/2016 - 01:43

Eligible patients may pay as little as $25* for a prescription of either Quillivant XR or QuilliChew ER

We designed a program to help make prescriptions more affordable for eligible patients.

With the Co-pay Card, eligible patients may pay less than $1 a day for their Quillivant XR or QuilliChew ER prescription. A monthly prescription cost of $25 is comparable to generic extended-release methylphenidate.

Answer 3 simple questions to see if you’re eligible to register for or activate a card:

IMPORTANT SAFETY INFORMATION and INDICATION

Quillivant XR and QuilliChew ER are federally controlled substances (CII) because they can be abused or lead to dependence. Keep Quillivant XR and QuilliChew ER in a safe place to prevent misuse and abuse. Selling or giving away Quillivant XR or QuilliChew ER may harm others and is against the law. Tell your doctor if you or your child have (or have a family history of) ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Quillivant XR or QuilliChew ER should not be taken if you or your child are allergic to methylphenidate hydrochloride, or any of the ingredients in Quillivant XR or QuilliChew ER, or are taking or have taken within the past 14 days an antidepression medicine called a monoamine oxidase inhibitor or MAOI.

The following have been reported with the use of methylphenidate hydrochloride and other stimulant medicines:

Heart-related problems:

Sudden death in patients who have heart problems or heart defects

Stroke and heart attack in adults

Increased blood pressure and heart rate

Your healthcare provider should check you or your child’s blood pressure and heart rate regularly during treatment with Quillivant XR or QuilliChew ER

Mental (psychiatric) problems:

New or worse behavior and thought problems

New or worse bipolar illness

May cause new psychotic symptoms (such as hearing voices, believing things that are not true, are suspicious) or new manic symptoms

Fingers or toes may feel numb, cool, painful, or may change color from pale, to blue, to red

Call your healthcare provider right away if you or your child have any:

Heart-related symptoms such as chest pain, shortness of breath, or fainting

New or worsening mental (psychiatric) symptoms or new manic symptoms

Signs of unexplained wounds appearing on fingers or toes while taking Quillivant XR or QuilliChew ER

Quillivant XR or QuilliChew ER may not be right for you or your child. Tell your healthcare provider if:

You or your child have, or have a family history of, heart problems, heart defects, or high blood pressure

You or your child have mental problems, including psychosis (hearing voices, believing things that are not true, are suspicious), mania, bipolar illness, or depression, or a family history of suicide, bipolar illness, or depression

You or your child have circulation problems in fingers and toes

You or your child have phenylketonuria (PKU). QuilliChew ER contains phenylalanine as part of the artificial sweetener, aspartame. The artificial sweetener may be harmful to people with PKU or who are allergic to phenylalanine

You are pregnant or plan to become pregnant. It is not known if Quillivant XR or QuilliChew ER will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant

You are breastfeeding or plan to breastfeed. Quillivant XR or QuilliChew ER passes into your breast milk. You and your doctor should decide if you will take Quillivant XR or QuilliChew ER or breastfeed

What should I avoid while taking Quillivant XR or QuilliChew ER? Quillivant XR and QuilliChew ER should not be taken with MAOI medicines or if you stopped taking an MAOI in the last 14 days. Do not drink alcohol while taking Quillivant XR or QuilliChew ER. This may cause a faster release of your methylphenidate dose.

See “What is the most important information I should know about Quillivant XR or QuilliChew ER?” for information on reported heart and mental problems

Other serious side effects include:

Painful and prolonged erections (priapism) have occurred with methylphenidate. If you or your child develop priapism seek medical help right away. Because priapism can cause long-lasting damage, it should be checked by a healthcare provider right away

Slowing of growth (height and weight) in children

Common side effects include:

Decreased

Indigestion

Irritability

appetite

Stomach pain

Mood swings

Trouble sleeping

Weight loss

Fast heart beat

Nausea

Anxiety

Increased blood

Vomiting

Dizziness

pressure

These are not all the possible side effects of Quillivant XR and QuilliChew ER.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

INDICATION

Quillivant XR and QuilliChew ER are central nervous system stimulant prescription medicines. Quillivant XR is a liquid medicine that you take by mouth. QuilliChew ER is a chewable tablet. Quillivant XR and QuilliChew ER are used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Quillivant XR and QuilliChew ER may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.

It is not known if Quillivant XR or QuilliChew ER are safe and effective in children under 6 years of age.

This co-pay card is not health insurance. The co-pay card is only accepted at participating pharmacies. For any questions, please call 1-877-776-7246, or write: Pfizer, ATTN: Pfizer ADHD Medication, PO Box 4934, Warren, NJ 07059-6600. No membership fees required. Eligible insured patients’ savings limited to $140 per 30 days for up to 12 uses within the offering period. Card may be used once every 30 days. Maximum savings of $1680 per year. Cash paying patients’ savings limited to $100 per 30 days for up to 12 uses within the offering period. Card may be used once every 30 days. Maximum savings of $1200 per year.

Patients should always ask their doctors for medical advice about adverse events. You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch, where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit Medwatch or call 1-800-FDA-1088.

For more information about Quillivant XR or QuilliChew ER, call 1-855-478-4597, 9 AM to 7 PM Eastern time, Monday through Friday to speak to a live operator.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

You are leaving this Web site.

You are leaving this Web site. Links to all outside Web sites are provided as a convenience to our visitors and do not imply an endorsement or recommendation by Pfizer Inc. Pfizer Inc accepts no responsibility or liability for the content or services of other Web sites.

Terms and Conditions

By using the Quillivant XR and QuilliChew ER Co-pay Card, you acknowledge that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:

Co-pay cards are not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, Tricare, or other federal or state healthcare programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico [formerly known as “La Reforma De Salud”])

Co-pay cards are not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse you for the entire cost of your prescription drugs

Insureds must be 18 or older; patients must be 6 or older

Eligible insured patients may pay as little as $25 for each prescription

If your out-of-pocket costs are $165 or less, you will pay $25

If your out-of-pocket costs are more than $165, you will save $140 off your costs

Savings are limited to $140 per 30 days for up to 12 uses within the offering period

Card may be used once every 30 days. Maximum savings of $1680 per year

Each patient is limited to one active co-pay card at a time during this offering period and the co-pay cards are not transferable

Cash payers will receive up to $100 off each prescription fill

If your out-of-pocket costs are $125 or less, you will pay $25

If your out-of-pocket costs are more than $125 you will save $100 off your costs

Savings are limited to $100 per 30 days for up to 12 uses within the offering period

Card may be used once every 30 days. Maximum savings of $1200 per year

You must deduct the value received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf

The co-pay card cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription

The co-pay card will be accepted only at participating pharmacies

This co-pay card is not health insurance

This coupon is not valid where prohibited by law

This offer is good only in the United States and Puerto Rico

Pfizer reserves the right to rescind, revoke, or amend the co-pay card without notice

Offer valid from 1/1/17 to 12/31/18. No membership fees apply

For help with the Quillivant XR and QuilliChew ER Co-pay Card, call 1-877-776-7246, or write:

IMPORTANT SAFETY INFORMATION and INDICATION

Quillivant XR and QuilliChew ER are federally controlled substances (CII) because they can be abused or lead to dependence. Keep Quillivant XR and QuilliChew ER in a safe place to prevent misuse and abuse. Selling or giving away Quillivant XR or QuilliChew ER may harm others and is against the law. Tell your doctor if you or your child have (or have a family history of) ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Quillivant XR or QuilliChew ER should not be taken if you or your child are allergic to methylphenidate hydrochloride, or any of the ingredients in Quillivant XR or QuilliChew ER, or are taking or have taken within the past 14 days an antidepression medicine called a monoamine oxidase inhibitor or MAOI.

The following have been reported with the use of methylphenidate hydrochloride and other stimulant medicines:

Heart-related problems:

Sudden death in patients who have heart problems or heart defects

Stroke and heart attack in adults

Increased blood pressure and heart rate

Your healthcare provider should check you or your child’s blood pressure and heart rate regularly during treatment with Quillivant XR or QuilliChew ER

Mental (psychiatric) problems:

New or worse behavior and thought problems

New or worse bipolar illness

May cause new psychotic symptoms (such as hearing voices, believing things that are not true, are suspicious) or new manic symptoms

Fingers or toes may feel numb, cool, painful, or may change color from pale, to blue, to red

Call your healthcare provider right away if you or your child have any:

Heart-related symptoms such as chest pain, shortness of breath, or fainting

New or worsening mental (psychiatric) symptoms or new manic symptoms

Signs of unexplained wounds appearing on fingers or toes while taking Quillivant XR or QuilliChew ER

Quillivant XR or QuilliChew ER may not be right for you or your child. Tell your healthcare provider if:

You or your child have, or have a family history of, heart problems, heart defects, or high blood pressure

You or your child have mental problems, including psychosis (hearing voices, believing things that are not true, are suspicious), mania, bipolar illness, or depression, or a family history of suicide, bipolar illness, or depression

You or your child have circulation problems in fingers and toes

You or your child have phenylketonuria (PKU). QuilliChew ER contains phenylalanine as part of the artificial sweetener, aspartame. The artificial sweetener may be harmful to people with PKU or who are allergic to phenylalanine

You are pregnant or plan to become pregnant. It is not known if Quillivant XR or QuilliChew ER will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant

You are breastfeeding or plan to breastfeed. Quillivant XR or QuilliChew ER passes into your breast milk. You and your doctor should decide if you will take Quillivant XR or QuilliChew ER or breastfeed

What should I avoid while taking Quillivant XR or QuilliChew ER? Quillivant XR and QuilliChew ER should not be taken with MAOI medicines or if you stopped taking an MAOI in the last 14 days. Do not drink alcohol while taking Quillivant XR or QuilliChew ER. This may cause a faster release of your methylphenidate dose.

See “What is the most important information I should know about Quillivant XR or QuilliChew ER?” for information on reported heart and mental problems

Other serious side effects include:

Painful and prolonged erections (priapism) have occurred with methylphenidate. If you or your child develop priapism seek medical help right away. Because priapism can cause long-lasting damage, it should be checked by a healthcare provider right away

Slowing of growth (height and weight) in children

Common side effects include:

Decreased

Indigestion

Irritability

appetite

Stomach pain

Mood swings

Trouble sleeping

Weight loss

Fast heart beat

Nausea

Anxiety

Increased blood

Vomiting

Dizziness

pressure

These are not all the possible side effects of Quillivant XR and QuilliChew ER.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

INDICATION

Quillivant XR and QuilliChew ER are central nervous system stimulant prescription medicines. Quillivant XR is a liquid medicine that you take by mouth. QuilliChew ER is a chewable tablet. Quillivant XR and QuilliChew ER are used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Quillivant XR and QuilliChew ER may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.

It is not known if Quillivant XR or QuilliChew ER are safe and effective in children under 6 years of age.

This co-pay card is not health insurance. The co-pay card is only accepted at participating pharmacies. For any questions, please call 1-877-776-7246, or write: Pfizer, ATTN: Pfizer ADHD Medication, PO Box 4934, Warren, NJ 07059-6600. No membership fees required. Eligible insured patients’ savings limited to $140 per 30 days for up to 12 uses within the offering period. Card may be used once every 30 days. Maximum savings of $1680 per year. Cash paying patients’ savings limited to $100 per 30 days for up to 12 uses within the offering period. Card may be used once every 30 days. Maximum savings of $1200 per year.

Patients should always ask their doctors for medical advice about adverse events. You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch, where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit Medwatch or call 1-800-FDA-1088.

For more information about Quillivant XR or QuilliChew ER, call 1-855-478-4597, 9 AM to 7 PM Eastern time, Monday through Friday to speak to a live operator.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.